Schedule of Pharmaceutical Benefits - 1 February 2021

PBAC

1 February 2021 - The February 2021 issue of the Schedule of Pharmaceutical Benefits is out and now in effect.

The February issue of the Schedule includes a few new/revised listings:

  • Carfilzomib (Kyprolis) - restriction change
  • Lisdexamphetamine mesylate (Vyvanse) - restriction change
  • Selexipag (Uptravi) - new medicine
  • Bricanyl (terbutaline sulphate) - new formulation

Read Summary of Changes


Michael Wonder

Posted by:

Michael Wonder